A detailed history of Avalon Global Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Avalon Global Asset Management LLC holds 10,000 shares of LLY stock, worth $8.3 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$8.3 Million
Previous $7.78 Million 16.38%
% of portfolio
2.06%
Previous 1.12%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $3.51 Million - $4.69 Million
10,000 New
10,000 $4.69 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Avalon Global Asset Management LLC Portfolio

Follow Avalon Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Global Asset Management LLC with notifications on news.